Simplified QC for Pharmaceutical Elemental Impurity Analysis

White Paper USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution Elemental Impurity Analysis Requirements Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. To achieve this, potentially harmful contaminants—including elemental…

White Paper USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution Elemental Impurity Analysis Requirements Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. Potentially toxic and harmful contaminants—including elemental impurities—must…

Application Note Pharmaceutical Elemental Impurities in Aspirin: USP <232>/<233> and ICH Q3D Methods Using ICP-OES Validation of the USP <232>/<233> method on an Agilent ICP-OES Author Lindsey Whitecotton, Greg Gilleland, Elizabeth Kulikov, and Amir Liba Agilent Technologies, Inc., USA Samina…

Agilent ICP-MS Journal July 2017 – Issue 69 Inside this Issue 2-3 Automated Analysis of Environmental Samples using prepFAST-ICP-MS 4-5 ICP-MS for Elemental Impurities Analysis in Pharmaceuticals According to USP <232>/<233> and ICH Q3D 6 New! ICP-MS…